ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

‘Groundbreaking’ stem cell research withdrawn – Haaretz

Haaretz‘Groundbreaking’ stem cell research withdrawn. Scientist said he’d found simple way to revert mature cells into embryonic-like state. But it couldn’t be reproduced. By Reuters | Mar. 10, 2014 | 11:00 PM … …read more   &nbs… Continue reading

2014-03-10 Michael Zand NEWS

Several FDA-approved anti-cancer drugs induce stem cell tumors, perhaps … – Science Codex

Science CodexShe adds, “We did these experiments in the fly because Drosophila stem cells, in the intestine, are very much like the stem cells in our intestine, and it’s a lot easier to do experiments in flies than humans or even mice.” Further, Markstein explains … and more …read more   &nbs… Continue reading

2014-03-10 Michael Zand NEWS

Japanese scientist wants own “breakthrough” stem cell study retracted – CBS News

Japanese scientist wants own “breakthrough” stem cell study retractedCBS NewsResearchers in Boston and Japan said in January they created stem cells from various tissues of newborn mice. If the same technique worked in humans, it could provide a new way to grow tissue for treating illnesses like diabetes and Parkinson’s disease … …read more   &nbs… Continue reading

2014-03-10 Michael Zand NEWS

Several FDA-approved anti-cancer drugs induce stem cell tumors, perhaps … – EurekAlert (press release)

Several FDA-approved anti-cancer drugs induce stem cell tumors, perhaps …EurekAlert (press release)AMHERST, Mass.– Using a new approach to systematically test chemotherapy drugs in an unusual animal model, a research team led by University of Massachusetts Amherst molecular biologist Michele Markstein, with Norbert Perrimon at Harvard Medical … and more …read more   &nbs… Continue reading

2014-03-10 Michael Zand NEWS

Scientist urges withdrawal of his own “breakthrough” stem cell research – Firstpost

Scientist urges withdrawal of his own “breakthrough” stem cell researchFirstpostRobin Lovell-Badge, a stem cell expert at Britain’s National Institute for Medical Research, cautioned against premature assumptions on whether the research was flawed. “I have an open mind on this,” he told Reuters. “I’m waiting to hear from several … …read more   &nbs… Continue reading

2014-03-10 Michael Zand NEWS

Several FDA-approved anti-cancer drugs induce stem cell tumors, perhaps … – Medical Xpress

Medical XpressDrosophila intestines provide ‘ready-made stem cell microenvironments’ that are ‘difficult-to-impossible’ to create in petri dishes, offering an unconventional screen that allows researchers to test drugs in vivo. Credit: University of Massachusetts … and more …read more   &nbs… Continue reading

2014-03-10 Michael Zand NEWS

Scientist urges withdrawal of his own ‘breakthrough’ stem cell research – Reuters

ReutersRobin Lovell-Badge, a stem cell expert at Britain’s National Institute for Medical Research, cautioned against premature assumptions on whether the research was flawed. “I have an open mind on this,” he told Reuters. “I’m waiting to hear from several …Co-Author of Stem–Cell Paper Asks for RetractionWall Street JournalCall for acid-bath stem–cell paper to be retractedNature.com … Continue reading

2014-03-10 Michael Zand NEWS

Stem cells: Scientist asks for research to be withdrawn – BBC News

BBC NewsA Japanese scientist behind a seemingly groundbreaking stem cell study says the findings should be withdrawn amid doubts over its quality. It was reported in January that dipping cells in acid could cheaply and quickly convert them into stem cells. …read more   &nbs… Continue reading

2014-03-10 Michael Zand NEWS
  • 1
  • …
  • 3,244
  • 3,245
  • 3,246
  • 3,247
  • 3,248
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.